Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Diabetic dyslipoproteinemia].

H C Geiss¹, K Parhofer

¹Medizinische Klinik I, Johannes-Gutenberg-Universität, Mainz. geiss@endokrinologie.klinik.uni-mainz.de

MMW Fortschritte Der Medizin

|May 4, 2006

Summary

Diabetic dyslipoproteinemia, common in type 2 diabetes, involves abnormal lipid levels and increased cardiovascular risk. Management often requires medication beyond lifestyle changes to control triglycerides and cholesterol.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

MMW Fortschritte der Medizin·2020

Same author

Complications and monitoring - Guidelines on Parenteral Nutrition, Chapter 11.

German medical science : GMS e-journal·2010

Same author

[Statines for all or individualized lipid lowering therapy?].

MMW Fortschritte der Medizin·2009

Same author

[Treatment of hyperlipidemia in the elderly].

MMW Fortschritte der Medizin·2009

Same author

Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statins.

Atherosclerosis·2005

Same author

Effect of pioglitazone on lipids in well controlled patients with diabetes mellitus type 2 -- results of a pilot study.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2005

Area of Science:

Endocrinology and Metabolism
Cardiovascular Medicine
Lipidology

Context:

Diabetic dyslipoproteinemia is a key feature of type 2 diabetes mellitus and metabolic syndrome.
Pathogenesis involves insulin resistance, hyperglycemia, and abdominal obesity, leading to increased hepatic VLDL secretion.

Purpose:

To outline the characteristics and clinical implications of diabetic dyslipoproteinemia.
To discuss the management strategies for lipid abnormalities in diabetic patients.

Summary:

Characterized by elevated triglycerides and cholesterol, decreased HDL cholesterol, and altered LDL particle composition.
Contributes significantly to the heightened cardiovascular risk in diabetic individuals.
May also manifest as hypertriglyceridemia in type 1 diabetes mellitus.

Impact:

Highlights the link between dyslipidemia and cardiovascular complications in diabetes.
Emphasizes the need for pharmacological intervention when lifestyle modifications and glycemic control are insufficient.
Suggests statins, combination therapy, or fibrates as potential treatment options based on lipid profiles.

Related Experiment Videos